Marco Ruella, MD^1,2,3,4, Mireia Uribe-Herranz^5*, Silvia Beghi^5*, Kalpana Parvathaneni, PhD^6*, Nektarios Kostopoulos^5*, Guido Ghilardi, MD^7*, Kimberly Amelsberg^5*, Yong Gu Gu Lee, PhD⁷, Raymone Pajarillo, MS^7*, Noelle V Frey, MD, MS⁸, Simon F Lacey, PhD⁷, Khatuna Gabunia^5*, John Scholler^7*, Elise A Chong, MD^7,9, Carl H June, MD¹⁰, David L. Porter, MD¹¹, Stephen J. Schuster, MD^4,11, Vijay Bhoj, MD, PhD¹² and Andrea Facciabene, PhD^5*

¹Division of Hematology-Oncology and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
²Center for Cellular Immunotherapies and Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA
³Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
⁴Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵University of Pennsylvania, Philadelphia, PA
⁶Department of Pathology and laboratory medicine, University of Pennsylvania, Philadelphia, PA
⁷Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
⁸Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA
⁹Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
¹⁰Center for Cellular Immunotherapies (CCI), The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
¹¹Division of Hematology-Oncology/Department of Medicine, University of Pennsylvania, Philadelphia, PA
¹²Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Zachary Jackson^1*, Changjin Hong, PhD^2*, Robert Schauner^3*, Boro Dropulic, PhD, MBA^4*, Paolo F. Caimi, MD⁵, Marcos J.G. de Lima, MD⁶, Kalpana Gupta, PhD^7*, Jane Reese^8*, Tae Hyun Hwang, PhD^9* and David Wald, MD, PhD^10*

¹Pathology, Case Western Reserve University, Cleveland, OH
²Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH
³Case Western Reserve University, Cleveland, OH
⁴Lentigen Technology Inc., A Miltenyi Biotec Company, Gaithersburg, MD
⁵University Hospitals of Cleveland, Cleveland, OH
⁶Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁷Case Western Reserve University, Cleveland
⁸Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
⁹Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
¹⁰Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH

Brian T. Hill, MD¹, Caroline J Roth, MS^2*, Rachel Kositsky, BS^2*, Tushar Dave, MS^2*, Cassandra Love², Matthew McKinney, MD³, Ahmed Galal, MD⁴, Jadee L Neff, MD, PhD^5*, Agrima Mian, MD⁶, Ellen Kendall, BS^7*, Sarah L. Ondrejka, DO^8*, Matthew Chiaramonte, BA^9*, Govind Bhagat, M.D.¹⁰, Kenneth Ofori, MD, MHS^11*, Ran Reshef, MD, MSc¹², Alexandra E. Kovach, MD¹³, Tarsheen Sethi, MD, MBBS¹⁴, Emily F Mason, MD, PhD^15*, Shakthi Bhaskar, MD¹⁵, Olalekan O. Oluwole, MBBS, MPH¹⁵, Christopher Pallas, MD^16*, Nilanjan Ghosh, MD, PhD¹⁷, Robert Ferdman, MD^18*, George L. Chen, MD¹⁹, Francisco J. Hernandez-Ilizaliturri, MD²⁰, Joanna C. Zurko, MD²¹, Ashley Cunningham, MD^22*, Nirav N. Shah, MD²³, Boyu Hu, MD^24*, Deborah M. Stephens²⁵, Monalisa Ghosh, MD²⁶, Neil Bailey, MSc^27*, Krish Patel, MD²⁸, John M. Pagel, MD, PhD²⁷, Kavya Kannamma Kannan, MBBS²⁹, Eric D. Hsi, MD³⁰, Rakhee Vaidya, MD³¹, Andrew Ip, MD, MSc³², Andre H. Goy, MD^33*, Swetha Kambhampati, MD^34*, Robert S. Ohgami, MD, PhD³⁵, Charalambos Andreadis, MD, MS³⁶, Elizabeth Thacker^37*, Chrissie Rozzi^37*, Clay Parker^38*, Lanie Happ^37* and Sandeep S. Dave, MD, MS³⁹

¹Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
²Duke University Medical Center, Durham, NC
³Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
⁴Duke Cancer Institute, Durham, NC
⁵Department of Pathology, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC
⁶Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
⁷Case Western Reserve University School of Medicine, Cleveland, OH
⁸Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH
⁹Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
¹⁰Columbia University Medical Center, New York, NY
¹¹Department of Pathology & Cell Biology, Columbia University, New York, NY
¹²Columbia Center for Translational Immunology, Columbia University, New York, NY
¹³Department of Pathology, Vanderbilt University, Nashville, TN
¹⁴Department of Medicine/ Division of Hematology-Oncology, Vanderbilt Medical Center, Nashville, TN
¹⁵Vanderbilt University Medical Center, Nashville, TN
¹⁶Levine Cancer Institute, Charolotte, NC
¹⁷Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, NC
¹⁸Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁹Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
²⁰Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
²¹Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
²²Department of Pathology, Medical College of Wisconsin, Milwaukee, WI
²³Medical College of Wisconsin, Milwaukee, WI
²⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²⁵Huntsman Cancer Institute, Huntsman Cancer Institute, Salt Lake City, UT
²⁶Michigan Medicine University of Michigan, Ann Arbor, MI
²⁷Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
²⁸Swedish Cancer Institute, Seattle, WA
²⁹Wake Forrest University, Winston Salem, NC
³⁰Department of Pathology, Wake Forest Baptist Medical Center, Winston Salem, NC
³¹Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC
³²Division of Lymphoma, Division of Outcomes and Value Research, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
³³John Theurer Cancer Center Hackensack, Hackensack, NJ
³⁴University of California San Francisco, San Francisco, CA
³⁵Pathology, University of California, San Francisco, San Francisco, CA
³⁶Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
³⁷Data Drive Biosciences, Durham, NC
³⁸Data Driven Bioscience, Durham, NC
³⁹Duke Cancer Institute, Duke University, Durham, NC

J. Joseph Melenhorst, PhD^1,2, Gregory M Chen^3*, Meng Wang, BS^1*, David L. Porter, MD^4*, Peng Gao^5*, Shovik Bandyopadhyay^6*, Iulian Pruteanu-Malinici, DPhil^7*, Christopher L Nobles, PhD^8*, Sayantan Maji, PhD^9*, Noelle V Frey, MD, MS¹⁰, Saar Gill, MD, PhD¹¹, Lifeng Tian, PhD^12*, Irina Kulikovskaya^12*, Megan M Davis, PhD^2*, Joseph A Fraietta, PhD^8*, Jennifer L Brogdon, PhD^13*, Regina Young^12*, David E Ambrose, BS^2*, Anne Chew, PhD^12*, Bruce L Levine, PhD², Don L. Siegel, MD, PhD¹⁴, Cécile Alanio, PhD^15*, E. John Wherry, PhD^12*, Frederic D. Bushman, PhD^16*, Simon F Lacey, PhD^17*, Kai Tan, PhD^18* and Carl H June, MD²

¹Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
³Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, PA
⁴Division of Hematology-Oncology/Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA
⁶Graduate Group in Cell & Molecular Biology, University of Pennsylvania, Philadelphia, PA
⁷Exploratory Immuno-Oncology, Novartis Pharmaceuticals Corporation, Medford, MA
⁸Department of Microbiology, University of Pennsylvania, Philadelphia, PA
⁹Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
¹⁰Abramson Cancer Center, University of Pennsylvania, Narberth, PA
¹¹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹²University of Pennsylvania, Philadelphia, PA
¹³Novartis Institutes for BioMedical Research, Cambridge, MA
¹⁴Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
¹⁵Institut Curie, Paris, France
¹⁶Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
¹⁷Center for Cellular Immunotherapies, University of Pennsylvania, Media, PA
¹⁸Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Caroline Diorio, MD¹, Rawan Shraim, MSc^2*, Regina M. Myers, MD³, Chakkapong Burudpakdee, BS^4*, Allison Barz Leahy, MD^3*, Richard Aplenc, MD, PhD⁵, Michele P. Lambert, MD⁶, Hamid Bassiri, MD/PhD^7*, Edward M Behrens, MD^7*, Vanessa E. Gonzalez^8*, Fang Chen^9*, Bruce L Levine, PhD⁹, Shannon L. Maude, MD, PhD^10,11, Amanda M. DiNofia, MD^12*, Alix E. Seif, MD¹², J. Joseph Melenhorst, PhD¹³, Simon F Lacey, PhD⁹, Carl H June, MD¹⁴, David Barrett, MD PhD^15*, Stephan A. Grupp, MD, PhD^16,17 and David T. Teachey, MD^7,18

¹Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
²Children's Hospital of Philadelphia, Philadelphia, PA
³Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
⁴Immune Dysregulation Frontier Program, Children's Hospital of Philadelphia, Philadelphia, PA
⁵Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
⁶Department of Pediatrics, Division of Hematology, Children's Hosp. of Phila., Philadelphia, PA
⁷Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
⁸Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, PA
⁹Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
¹⁰The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
¹¹Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
¹²Center for Childhood Cancer Research, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
¹³Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
¹⁴Center for Cellular Immunotherapies (CCI), The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
¹⁵Tmunity, Philadelphia, PA
¹⁶Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
¹⁷Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA
¹⁸Perelman School of Medicine University of Pennsylvania, Philadelphia, PA

Katelyn Burleigh, PhD^1*, Anna Kus^2*, Alice Long, PhD^2*, Michael C. Jensen, MD^3*, Seth Masters, PhD^4*, James E Vince, PhD^4*, Bobbie-Jo Webb-Robertson, PhD^5*, Rebecca A Gardner, MD^3,6 and Heather Gustafson, PhD^1*

¹Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA
²Benaroya Research Institute, Seattle, WA
³Seattle Children's Therapeutics, Seattle Children's Research Institute, Seattle, WA
⁴The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
⁵Pacific Northwest National Laboratory, Richland, WA
⁶Division of Hematology-Oncology, Seattle Children's Hospital, Seattle, WA